The increased cross-reactivity against the TAA in HIV-positive subjects, prior and after the “ex vivo” expansion with HIV peptides, shows a clear trend that does not reach the statistical significance (Fig. 5 E–L).
← all excerpts
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case.
1
—
—